Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm, Nanogen, Sangamo File for IPO, Many Others Get Ready

Premium

W

ASHINGTON--The list of genomics companies planning initial public offerings continues to grow, with Paradigm Genetics, Nanogen, and Sangamo Biosciences about to join the fray. All three have filed IPO registration statements with the Securities and Exchange Commission.

Paradigm is industrializing the process of gene function determination for four major sectors: crop production, nutrition, human health, and industrial products. Nanogen integrates microelectronics and molecular biology into a technology platform with commercial applications in genomics and related industries and possibly electronics and telecommunications. Sangamo develops novel transcription factors for gene expression regulation.

Other companies in the genomics and bioinformatics industry that have been rumored to be on the verge of making offerings on US stock exchanges include Compugen of Tel Aviv, Israel; DeCode Genetics of Reykjavik, Iceland; Exelixis of South San Francisco, Calif.; Lexicon Genetics of the Woodlands, Texas; Lion Bioscience of Heidelberg, Germany; NetGenics of Cleveland; and Physiome Sciences of Princeton, NJ, a developer of computer-based models of organs for use in drug discovery.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.